PFIZER INC Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Amount
PFIZER INC (PFE) reported Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Amount of $1.30 billion for the 12-month period ending 2017-12-31, per its 10-K filed 2020-02-27.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationRepatriationOfForeignEarnings · last filed 2020-02-27
- PFIZER INC effective income tax rate reconciliation, repatriation of foreign earnings, amount for fiscal 2017 was $1.30B, a 18.18% increase from fiscal 2016.
- PFIZER INC effective income tax rate reconciliation, repatriation of foreign earnings, amount for fiscal 2016 was $1.10B, a 47.62% decline from fiscal 2015.
- PFIZER INC effective income tax rate reconciliation, repatriation of foreign earnings, amount for fiscal 2015 was $2.10B, a 4.55% decline from fiscal 2014.
- PFIZER INC effective income tax rate reconciliation, repatriation of foreign earnings, amount for fiscal 2014 was $2.20B, a 4.35% decline from fiscal 2013.
| Period end | Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Amount 12 month |
|---|---|
| 2017-12-31 | $1.30B 10-K · filed 2020-02-27 |
| 2016-12-31 | $1.10B 10-K · filed 2019-02-28 |
| 2015-12-31 | $2.10B 10-K · filed 2018-02-22 |
| 2014-12-31 | $2.20B 10-K · filed 2017-02-23 |
| 2013-12-31 | $2.30B 10-K · filed 2016-02-29 |
| 2012-12-31 | $2.20B 10-K · filed 2015-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |